Cited by 149T-cell and B-cell ImmunologySignaling Pathways in DiseaseImmunotherapy and Immune Responses

CD28: a signalling perspective

Open access
WARD, Stephen G·1996·Biochemical Journal

Abstract

CD28 and the related molecule cytotoxic T lymphocyte-associated molecule-4 (CTLA-4), together with their natural ligands B7.1 and B7.2, have been implicated in the differential regulation of several immune responses. CD28 provides signals during T cell activation which are required for the production of interleukin 2 and other cytokines and chemokines, and it has also been implicated in the regulation of T cell anergy and programmed T cell death. The biochemical signals provided by CD28 are cyclosporin A-resistant and complement those provided by the T cell antigen receptor to allow full activation of T cells. Multiple signalling cascades which may be independent of, or dependent on, protein tyrosine kinase activation have been demonstrated to be activated by CD28, including activation of phospholipase C, p21ras, phosphoinositide 3-kinase, sphingomyelinase/ceramide and 5-lipoxygenase. The relative contributions of these cascades to overall CD28 signalling are still unknown, but probably depend on the state of activation of the T cell and the level of CD28 activation. The importance of these signalling cascades (in particular the phosphoinositide 3-kinase-mediated cascade) to functional indications of CD28 activation, such as interleukin 2 gene regulation, has been investigated using pharmacological and genetic manipulations. These approaches have demonstrated that CD28-activated signalling cascades regulate several transcription factors involved in interleukin 2 transcriptional activation. This review describes in detail the structure and expression of the CD28 and B7 families, the functional outcomes of CD28 ligation and the signalling events that are thought to mediate these functions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj3180361

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CD28 signaling is connected to higher Δ133p53 protein, because NF-κB and its downstream mTOR activation may suppress autophagy.

    “This finding links CD28 function to Δ133p53 upregulation at the protein level, since NF-κB and its activation of mTOR, a major downstream pathway activated by the CD28 signaling, may repress autophagy (36)(37)(38)(39)(40).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 229 · Cited by 149

Research works printed but not linked: 18

  1. Aruffo, A. and Seed, B. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 8573-8577
  2. Boussiotis, V. A., Freeman, G. J., Gribben, J. G., Daley, J., Gray, G. S. and Nadler, L. M. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 11059-11063
  3. Thompson, C. B., Lindsten, T., Ledbetter, J. A., Kunkel, S. L., Young, H. A., Emerson, S. G., Leiden, J. M. and June, C. H. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 1333-1337
  4. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Gray, G. and Nadler, L. M. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 6586-6590
  5. Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R. Q., Gibson, M. L., Zheng, X. G., Myrdal, S., Gordon, D., et al. (1992) Proc. Natl. Acad. Sci.
  6. Gribben, J., Freeman, G., Boussiotis, V., Rennert, P., Jellis, E., Greenfield, M., Barber, M., Restivo, V. A., Ke, G. S., Gray, G. and Nadler, L. (1995) Proc. Natl. Acad. Sci.
  7. Lenschow, D. J., Su, G. H., Zuckerman, L. A., Nabavi, N., Jellis, C. L., Gray, G. S., Miller, J. and Bluestone, J. A. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 11054-11058
  8. Park, D., Rho, H. and Rhee, S. G. (1991) Proc. Natl. Acad. Sci U.S.A. 99, 5453-5456 75
  9. Moriya, S., Kazlauskas, A., Akimoto, K., Hirai, S., Mizuno, K., Takenawa, T., Fukui, Y., Watanabe, Y., Ozaki, S. and Ohno, S. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 788-798 108
  10. Weng, Q. P., Andrabi, K., Klippel, A., Kozlowski, M. T., Williams, L. T. and Avruch, J. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 5744-5748 112
  11. Prasad, K. V., Cai, Y., Raab, M., Duckworth, B., Cantley, L., Shoelson, S. and Rudd, C. R. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 2834-2838 117 August, A., and Dupont, B. (1994) Int. Immunol. 6, 769-774 118
  12. Mathias, S., Dressler, K. A. and Kolesnick, R. N. (1992) Proc. Natl. Acad. Sci.
  13. Hutchcroft, J. and Bierer, B. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 3260-3264 133 August, A., Gibson, S., Kawakami, Y., Kawakami, T., Mills, G. and Dupont, B. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 9347-9351 134
  14. Raab, M., Cai, Y. C., Bunnell, S. C., Heyeck, S., Berg, L. J. and Rudd, C. E. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 8891-8895 136
  15. Nakanishi, S., Catt, K. and Balla, T. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 5317-5321 145
  16. Hutchcroft, J. E., Franklin, D. P., Tsai, B., Harrison-Findik, D., Varticovski, L. and Bierer, B. E. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 8808-8812 148
  17. Ghosh, P., Tan, T., Rice, N. R., Sica, A. and Young, H. A. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 1696-1700 191
  18. Parry, R. V. and Ward, S. G. (1996) Biochem. Soc. Trans. 24, 88S 200

Authors
WARD, S. G.
Affiliations
University of Bath (GB)
Corresponding author
WARD, Stephen G
Venue
Biochemical Journal
Published
1996-09-01
Volume
318
Issue
2
Pages
361-377
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W2404064356
Cited by
149
References
229
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 5 · 2019: 2 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 3
FWCI
1.18
Type
journal article
Language
en
Open access
Locations
  • Biochemical Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Wellcome Trust
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
CD28, CTLA-4, CD80, CD86, T cell costimulation, T cell activation, interleukin-2, phosphatidylinositol 3-kinase, phospholipase C, tyrosine kinase, T cell anergy, programmed cell death, signaling pathways, transcription factors, cyclosporine
MeSH terms
Abatacept, Amino Acid Sequence, Animals, Antigens, Differentiation, Binding Sites, Chromosome Mapping, Chromosomes, Human, Pair 2, Humans, Lymphocyte Activation, Models, Molecular, Protein-Tyrosine Kinases, T-Lymphocytes, Signal Transduction, Antigens, CD, Consensus Sequence, Apoptosis, Clonal Anergy, Phosphotransferases (Alcohol Group Acceptor), CD28 Antigens, Models, Immunological, Immunoconjugates, Phosphatidylinositol 3-Kinases, CTLA-4 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review